| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.3M | +167.3% |
| Cost of Revenue | $11.4M | +198.1% |
| R&D Expense | $12.1M | +2.4% |
| SG&A Expense | $77.6M | +45.5% |
| Operating Income | -$64.8M | -16.9% |
| Interest Expense | $7.6M | -6.8% |
| Income Tax | $0 | — |
| Net Income | -$85.1M | -55.4% |
| EPS (Basic) | -$1.91 | -34.5% |
| EPS (Diluted) | -$1.91 | -34.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.7M | +61.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $11.7M | +161.1% |
| Inventory | $13.9M | +57.3% |
| Current Assets | $105.8M | +13.9% |
| Total Assets | $107.5M | +13.8% |
| Current Liabilities | $14.9M | +13.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.5M | -19.1% |
| Capital Expenditures | $21K | -47.5% |
| Investing Cash Flow | $29.3M | +46.8% |
| Financing Cash Flow | $70.1M | +371.9% |
| Free Cash Flow | -$70.6M | -19.0% |
| Long-term Debt |
| $51.4M |
| +32.3% |
| Total Liabilities | $94.2M | +64.5% |
| Stockholders' Equity | $13.3M | -64.2% |